Pathstone Family Office, LLC Myriad Genetics Inc Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$14.51 - $20.99 $77,686 - $112,380	5,354 New	5,354 $77,000
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $298 - $474	-15 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $769 - $1,187	-72 Reduced 82.76%	15 $0
Q1 2020 Jun 11, 2020	BUY	$9.78 - $29.53 $704 - $2,126	72 Added 480.0%	87 $1,000
Q1 2020 May 07, 2020	BUY	$9.78 - $29.53 $146 - $442	15 New	15 $215,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $2,017 - $3,115	-89 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $2,423 - $4,054	89 New	89 $3,000

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.